ALRS
NASD Alerus Financial Corporation$31.07 ↑ +0.00 (+0.00%) Trading Up from the previous close of $31.07, $0.70 below the day’s high of $31.77
- YTD change
- +37.97%
- vs 20-day SMA
- -4.04%
- vs 200-day SMA
- +10.55%
Price ranges
Price & Performance
+6.05 (+24.18%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 18.9% away from all-time highs of $38.31
- ALRS is up 38% since the beginning of the year
- ALRS is up 44% over the past 12 months
- ALRS is down 6% over the past 1 month
- 6% of all ALRS investors are betting against ALRS
ALRS reads not so good: price sits above one of the two key moving averages, the 12-month move is +45.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -2.08%
- vs 8-day SMA
- -2.98%
No alerts for ALRS in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Alerus Financial Corp. engages in the provision of business and consumer financial products and services through its subsidiary, Alerus Financial NA. It operates through the following segments: Banking, Retirement and Benefit Services, and Wealth. The Banking segment provides lending and deposit products. The Retirement & Benefit Services segment consists of retirement plan administration and investment advisory services, employee stock ownership plan, fiduciary services, payroll, HSA, and other benefit services. The Wealth segment offers fiduciary services to consumer and commercial clients, including financial planning, investment management, personal and corporate trust services, estate administration, and custody services. The company was founded in 1879 and is headquartered in Grand Folks, ND.
Competitor comparison
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.